Picornavirus entry

Advances in Experimental Medicine and Biology

Volumn 790, Issue , 2013, Pages 24-41

  Bergelson, Jeffrey M ^a,b   Coyne, Carolyn B ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; DECAY ACCELERATING FACTOR; VIRUS RNA;

ARTICLE; CAVEOLA; COXSACKIE VIRUS A; COXSACKIE VIRUS B; CYTOLOGY; CYTOPLASM; ECHO VIRUS; ECHO VIRUS 1; ENCEPHALOMYOCARDITIS VIRUS; ENDOCYTOSIS; ENDOSOME; ENTEROVIRUS 71; FOOT AND MOUTH DISEASE VIRUS; NONHUMAN; PICORNAVIRUS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; RHINOVIRUS; VIRION; VIRUS ATTACHMENT; VIRUS CAPSID; VIRUS ENTRY; VIRUS GENOME; VIRUS MORPHOLOGY;

ANIMALS; ANTIGENS, CD55; COXSACKIE AND ADENOVIRUS RECEPTOR-LIKE MEMBRANE PROTEIN; ENDOCYTOSIS; HUMANS; PICORNAVIRIDAE; RECEPTORS, VIRUS; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

EID: 84881461260     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-7651-1_2     Document Type: Article

References (112)

1. Hogle JM, Chow M, Filman DJ. Three-dimensional structure of poliovirus at 2.9 A resolution. Science 1985; 229:1358-1365.
2. Rossmann MG, Arnold E, Erickson JW et al. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 1985; 317:145-153.
3. Acharya R, Fry E, Stuart D et al. The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature 1989; 337:709-716.
4. Chapman MS, Minor I, Rossmann MG et al. Human rhinovirus 14 complexed with antiviral compound R 61837. J Mol Biol 1991; 217:455-463.
5. Fox MP, Otto MJ, McKinlay MA. Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug. Antimicrob Agents Chemother 1986; 30:110-116.
6. Grant RA, Hiremath CN, Filman DJ et al. Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. Curr Biol 1994; 4:784-797.
7. Rogers JM, Diana GD, McKinlay MA. Pleconaril. A broad spectrum antipicornaviral agent. Adv Exp Med Biol 1999; 458:69-76.
8. Li Q, Yafal AG, Lee YM et al. Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature. J Virol 1994; 68:3965-3970.
9. Lewis JK, Bothner B, Smith TJ et al. Antiviral agent blocks breathing of the common cold virus. Proc Natl Acad Sci USA 1998; 95:6774-6778.
10. Olson NH, Kolatkar PR, Oliveria MA et al. Structure of a human rhinovirus complexed with its receptor molecule. Proc Natl Acad Sci USA 1993; 90:507-511.
11. Belnap DM, McDermott Jr BM, Filman DJ et al. Three-dimensional structure of poliovirus receptor bound to poliovirus. Proc Natl Acad Sci USA 2000; 97:73-78.
12. He Y, Bowman VD, Mueller S et al. Interaction of the poliovirus receptor with poliovirus. Proc Natl Acad Sci USA 2000; 97:79-84.
13. Xing L, Tjarnlund K, Lindqvist B et al. Distinct cellular receptor interactions in poliovirus and rhinoviruses. EMBO J 2000; 19:1207-1216.
14. He Y, Chipman PR, Howitt J et al. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat Struct Biol 2001; 8:874-878.
15. Casasnovas JM, Springer TA. Kinetics and thermodynamics of virus binding to receptor: studies with rhinovirus, intercellular adhesion molecule-1 (ICAM-1), and surface plasmon resonance. J Biol Chem 1995; 270:13216-13224.
16. McDermott Jr BM, Rux AH, Eisenberg RJ et al. Two distinct binding affinities of poliovirus for its cellular receptor. J Biol Chem 2000; 275:23089-23096.
17. Kolatkar PR, Bella J, Olson NH et al. Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor. EMBO J 1999; 18:6249-6259.
18. He Y, Lin F, Chipman PR et al. Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex. Proc Natl Acad Sci USA 2002; 99:10325-10329.
19. Pettigrew DM, Williams DT, Kerrigan D et al. Structural and functional insights into the interaction of echoviruses and decay-accelerating factor. J Biol Chem 2006; 281:5169-5177.
20. Powell RM, Ward T, Evans DJ et al. Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation. J Virology 1997; 71:9306-9312.
21. Milstone A, Petrella J, Sanchez M et al. Interaction with coxsackievirus and adenovirus receptor (CAR), but not with decay accelerating factor (DAF), induces A particle formation in a DAF-binding coxsackievirus B3 isolate. J Virol 2005; 79:655-660.
22. Crowell RL, Philipson L. Specific alterations of coxsackievirus B3 eluted from HeLa cells. J Virology 1971; 8:509-515.
23. Lonberg-Holm K, Korant BD. Early interaction of rhinoviruses with host cells. J Virol 1972; 9:29-40.
24. De Sena J, Mandel B. Studies on the in vitro uncoating of poliovirus. II. Characteristics of the membrane-modified particle. Virology 1977; 78:554-566.
25. Rosenwirth B, Eggers HJ. Early processes of echovirus 12-infection: elution, penetration, and uncoating under the influence of rhodanine. Virology 1979; 97:241-255.
26. Fricks CE, Hogle JM. Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding. J Virology 1990; 64:1934-1945.
27. McSharry JJ, Caliguiri LA, Eggars HJ. Inhibition of uncoating of poliovirus by arildone, a new antiviral drug. Virology 1979; 97:307-315.
28. Curry S, Chow M, Hogle JM. The poliovirus 135S particle is infectious. Journal of Virology 1996; 70:7125-7131.
29. Huang Y, Hogle JM, Chow M. Is the 135S poliovirus particle an intermediate during cell entry? J Virology 2000; 74:8757-8761.
30. Dove AW, Racaniello VR. Cold-adapted poliovirus mutants bypass a postentry replication block. J Virology 1997; 71:4728-4735.
31. Tosteson MT, Chow M. Characterization of the ion channels formed by poliovirus in planar lipid membranes. J Virol 1997; 71:507-511.
32. Tosteson MT, Wang H, Naumov A et al. Poliovirus binding to its receptor in lipid bilayers results in particle-specific, temperaturesensitive channels. J Gen Virol 2004; 85:1581-1589.
33. Danthi P, Tosteson M, Li QH et al. Genome delivery and ion channel properties are altered in VP4 mutants of poliovirus. J Virol 2003; 77:5266-5274.
34. Belnap DM, Filman DJ, Trus BL et al. Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus. J Virol 2000; 74:1342-1354.
35. Bubeck D, Filman DJ, Cheng N et al. The structure of the poliovirus 135S cell entry intermediate at 10-angstrom resolution reveals the location of an externalized polypeptide that binds to membranes. J Virol 2005; 79:7745-7755.
36. Lonberg-Holm K, Noble-Harvey J. Comparison of in vitro and cell-mediated alteration of a human Rhinovirus and its inhibition by sodium dodecyl sulfate. J Virol 1973; 12:819-826.
37. Xing L, Casasnovas JM, Cheng RH. Structural analysis of human rhinovirus complexed with ICAM-1 reveals the dynamics of receptor-mediated virus uncoating. J Virol 2003; 77:6101-6107.
38. Hewat EA, Neumann E, Blaas D. The concerted conformational changes during human rhinovirus 2 uncoating. Mol Cell 2002; 10:317-326.
39. Hewat EA, Blaas D. Cryoelectron microscopy analysis of the structural changes associated with human rhinovirus type 14 uncoating. J Virol 2004; 78:2935-2942.
40. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature 2003; 422:37-44.
41. Marsh M, Helenius A. Virus entry: open sesame. Cell 2006; 124:729-740.
42. Pelkmans L, Burli T, Zerial M et al. Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic. Cell 2004; 118:767-780.
43. Glebov OO, Bright NA, Nichols BJ. Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nat Cell Biol 2006; 8:46-54.
44. Yafal A, Kaplan G, Racaniello V et al. Characterization of poliovirus conformational alteration mediated by soluble cell receptors. Virology 1993; 197:501-505.
45. Hoover-Litty H, Greve JM. Formation of rhinovirus-soluble ICAM-1 complexes and conformational changes in the virion. J Virology 1993; 67:390-397.
46. Zeichhardt H, Wetz K, Willingmann P et al. Entry of poliovirus type 1 and Mouse Elberfeld (ME) virus into HEp-2. Cells: Receptor-mediated endocytosis and endosomal or lysosomal uncoating. J Virology 1985; 66:483-492.
47. Madshus IH, Olsnes S, Sandvig K. Mechanism of entry into the cytosol of poliovirus type 1: requirement for low pH. J Cell Biol 1984; 98:1194-1200.
48. Madshus IH, Olsnes S, Sandvig K. Requirements for poliovirus entry into cells at low pH. EMBO J 1984; 3:1945-1950.
49. Perez L, Carrasco L. Entry of poliovirus into cells does not require a low-pH step. J Virology 1993; 67:4543-4548.
50. DeTulleo L, Kirchhausen T. The clathrin endocytic pathway in viral infection. EMBO J 1998; 17:4585-4593.
51. Brandenburg B, Lee LY, Lakadamyali M et al. Imaging poliovirus entry in live cells. PLoS Biology 2007; 5:183-196.
52. Coyne CB, Kim KS, Bergelson JM. Poliovirus entry into human brain microvascular cells requires receptor-induced activation of SHP-2. EMBO Journal 2007; 26:submitted.
53. Brown F, Cartwright B. Dissociation of foot-and-mouth disease virus into its nucleic acid and protein components. Nature 1961; 192:1163-1164.
54. Baxt B, Bachrach H. Early interactions of foot-and-mouth disease virus with cultured cells. Virology 1980; 104:42-55.
55. O'Donnell V, LaRocco M, Duque H et al. Analysis of foot-and-mouth disease virus internalization events in cultured cells. J Virol 2005; 79:8506-8518.
56. Berryman S, Clark S, Monaghan P et al. Early events in integrin alphavbeta6-mediated cell entry of foot-and-mouth disease virus. J Virol 2005; 79:8519-8534.
57. Mason P, Baxt B, Brown F et al. Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor. Virology 1993; 192:568-577.
58. Snyers L, Zwickl H, Blaas D. Human rhinovirus type 2 is internalized by clathrin-mediated endocytosis. J Virol 2003; 77:5360-5369.
59. Bayer N, Schober D, Huttinger M et al. Inhibition of clathrin-dependent endocytosis has multiple effects on human rhinovirus serotype 2 cell entry. J Biol Chem 2001; 276:3952-3962.
60. Brabec M, Baravalle G, Blaas D et al. Conformational changes, plasma membrane penetration, and infection by human rhinovirus type 2: role of receptors and low pH. J Virol 2003; 77:5370-5377.
61. Nurani G, Lindqvist B, Casasnovas JM. Receptor priming of major group human rhinoviruses for uncoating and entry at mild low-pH environments. J Virol 2003; 77:11985-11991.
62. Khan AG, Pichler J, Rosemann A et al. Human rhinovirus type 54 infection via heparan sulfate is less efficient and strictly dependent on low endosomal pH. J Virol 2007; 81:4625-4632.
63. Vlasak M, Goesler I, Blaas D. Human rhinovirus type 89 variants use heparan sulfate proteoglycan for cell attachment. J Virol 2005; 79:5963-5970.
64. Reischl A, Reithmayer M, Winsauer G et al. Viral evolution toward change in receptor usage: adaptation of a major group human rhinovirus to grow in ICAM-1-negative cells. J Virol 2001; 75:9312-9319.
65. Brabec M, Schober D, Wagner E et al. Opening of size-selective pores in endosomes during human rhinovirus serotype 2 in vivo uncoating monitored by single-organelle flow analysis. J Virol 2005; 79:1008-1016.
66. Schober D, Kronenberger P, Prchla E et al. Major and minor receptor group human rhinoviruses penetrate from endosomes by different mechanisms. J Virol 1998; 72:1354-1364.
67. Bergelson JM, Shepley MP, Chan BMC et al. Identification of the integrin VLA-2 as a receptor for echovirus. Science 1992; 255:1718-1720.
68. King SL, Kamata T, Cunningham JA et al. Echovirus 1 interaction with the human very late antigen-2 (integrin 2γ1) I domain: identification of two independent virus contact sites distinct from the metal ion-dependent adhesion site. J Biol Chem 1997; 272:28518-28522.
69. Xing L, Huhtala M, Pietiainen V et al. Structural and functional analysis of integrin alpha2I domain interaction with echovirus 1. J Biol Chem 2004; 279:11632-11638.
70. Pietiainen V, Marjomaki V, Upla P et al. Echovirus 1 endocytosis into caveosomes requires lipid rafts, dynamin II, and signaling events. Mol Biol Cell 2004; 15:4911-4925.
71. Upla P, Marjomaki V, Kankaanpaa P et al. Clustering induces a lateral redistribution of alpha 2 beta 1 integrin from membrane rafts to caveolae and subsequent protein kinase C-dependent internalization. Mol Biol Cell 2004; 15:625-636.
72. Marjomaki V, Pietiainen V, Matilainen H et al. Internalization of echovirus 1 in caveolae. J Virol 2002; 76:1856-1865.
73. Bergelson JM, Cunningham JA, Droguett G et al. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275:1320-1323.
74. Tomko RP, Xu R, Philipson L. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci 1997; 94:3352-3356.
75. Martino TA, Petric M, Weingartl H et al. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B, and by swine vesicular disease virus. Virology 2000; 271:99-108.
76. Bergelson JM, Mohanty JG, Crowell RL et al. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virology 1995; 69:1903-1906.
77. Shafren DR, Bates RC, Agrez MV et al. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virology 1995; 69:3873-3877.
78. Triantafilou K, Triantafilou M. Lipid-raft-dependent Coxsackievirus B4 internalization and rapid targeting to the Golgi. Virology 2004; 326:6-19.
79. Chung SK, Kim JY, Kim IB et al. Internalization and trafficking mechanisms of coxsackievirus B3 in HeLa cells. Virology 2005; 333:31-40.
80. Stuart AD, Eustace HE, McKee TA et al. A novel cell entry pathway for a DAF-using human enterovirus is dependent on lipid rafts. J Virol 2002; 76:9307-9322.
81. Cohen CJ, Shieh JT-C, Pickles RJ et al. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc. Natl. Acad. Sci. USA 2001; 98:15191-15196.
82. Shieh JTC, Bergelson JM. Interaction with decay-accelerating factor facilitates coxsackievirus B infection of polarized epithelial cells. J Virology 2002; 76:9474-9480.
83. Coyne CB, Bergelson JM. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 2006; 124:119-131.
84. Coyne CB, Shen L, Turner JR et al. Coxsackievirus entry from epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5. Cell Host and Microbe 2007; 2:181-192.
85. Bubeck D, Filman DJ, Hogle JM. Cryo-electron microscopy reconstruction of a poliovirus-receptor-membrane complex. Nat Struct Mol Biol 2005; 12:615-618.
86. Tuthill TJ, Bubeck D, Rowlands DJ et al. Characterization of early steps in the poliovirus infection process: receptor-decorated liposomes induce conversion of the virus to membrane-anchored entry-intermediate particles. J Virol 2006; 80:172-180.
87. Brandenburg B, Zhuang X. Virus trafficking - learning from single-virus tracking. Nat Rev Microbiol 2007; 5:197-208.
88. Pelkmans L, Fava E, Grabner H et al. Genome-wide analysis of human kinases in clathrin- and caveolae/ raft-mediated endocytosis. Nature 2005; 436:78-86.
89. Mendelsohn CL, Wimmer E, Racaniello VR. Cellular receptor for poliovirus: Molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 1989; 56:855-865.
90. Greve JM, Davis G, Meyer AM et al. The major human rhinovirus receptor is ICAM-1. Cell 1989; 56:839-847.
91. Staunton DE, Merluzzi VJ, Rothlein R et al. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 1989; 56:849-853.
92. Tomassini JE, Graham D, DeWitt CM et al. cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1. Proc Natl Acad Sci U S A 1989; 86:4907-4911.
93. Hofer F, Gruenberger M, Kowalski H et al. Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc. Natl. Acad. Sci 1994; 91: 1839-1842.
94. Zautner AE, Korner U, Henke A et al. Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection. J Virol 2003; 77:10071-10077.
95. Bergelson JM, Chan M, Solomon K et al. Decay-accelerating factor, a glycosylphosphatidylinositolanchored complement regulatory protein, is a receptor for several echoviruses. Proc. Natl. Acad. Sci. USA 1994; 91:6245-6248.
96. Ward T, Pipkin PA, Clarkson NA et al. Decay accelerating factor (CD55) identified as a receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. EMBO J 1994; 13: 5070-5074.
97. Goodfellow IG, Sioofy AB, Powell RM et al. Echoviruses bind heparan sulfate at the cell surface. J Virol 2001; 75:4918-4921.
98. Shafren DR, Dorahy DJ, Greive SJ et al. Mouse cells expressing human intercellular adhesion molecule-1 are susceptible to infection by coxsackievirus A21. J Virol 1997; 71:785-789.
99. Shafren DR, Dorahy DJ, Ingham RA et al. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. J Virol 1997; 71:4736-4743.
100. Roivainen M, Piirainen L, Hovi T et al. Entry of coxsackievirus A9 into host cells: specific interactions with alpha v beta 3 integrin, the vitronectin receptor. Virology 1994; 203:357-365.
101. Triantafilou K, Fradelizi D, Wilson K et al. GRP78, a coreceptor for coxsackievirus A9, interacts with major histocompatability complex class I molecules which mediate virus internalization. J Virol 2002; 76:633-643.
102. Yamayoshi S, Yamashita Y, Li J et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 2009; 15:798-801.
103. Nishimura Y, Shimojima M, Tano Y et al. 2009. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med 2009; 15:794-797.
104. Tan CW, Poh CL, Sam IC, Chan YF. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J Virol 2013; 87:611-620.
105. Jackson T, Mould AP, Sheppard D et al. Integrin alphavbeta1 is a receptor for foot-and-mouth disease virus. J Virol 2002; 76:935-941.
106. Berinstein A, Roivainen M, Hovi T et al. Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J Virol 1995; 69:2664-2666.
107. Jackson T, Clark S, Berryman S et al. Integrin alphavbeta8 functions as a receptor for foot-and-mouth disease virus: role of the beta-chain cytodomain in integrin-mediated infection. J Virol 2004; 78:4533-4540.
108. Jackson T, Sheppard D, Denyer M et al. The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virus. J Virol 2000; 74:4949-4956.
109. Jackson T, Ellard FM, Ghazaleh RA et al. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J Virol 1996; 70: 5282-5287.
110. Huber SA. VCAM-1 is a receptor for encephalomyocarditis virus on murine vascular endothelial cells. J Virol 1994; 68:3453-3458.
111. Filman DJ, Syed R, Chow M et al. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J 1989; 8:1567-1579.
112. Yoder JD, Cifuente JO, Pan J et al. The crystal structure of a coxsackievirus B3-RD variant and a refined 9-angstrom cryo-electron microscopy reconstruction of the virus complexed with decay-accelerating factor (DAF) provide a new footprint of DAF on the virus surface. J Virol 2012; 86:12571-12581.